Document Type

Patent

Publication Date

2-12-1991

Comments

β-methyl-βbutyrate (HMB) has been found to be markedly more effective for activating the immune function of T lymphocytes of mammals than α-ketoisocaproate (KIC). For activation of the T lymphocytes, β-methyl-butyric acid or an edible water-soluble salt thereof is administered to the mammal by a route through which the HMB enters the blood of the mammal. The amount administered is sufficient for effective enhancement of the blastogenesis of their T lymphocytes. The method is adapted for use with domestic mammals, including particularly cattle, sheep, and swine. HMB can also be used with humans as an immune system stimulant.

Patent Number

US 4,992,470

ISURF Reference Number

1300

Assignee

Iowa State University Research Foundation, Inc.,

Application Number

US 07/477,240

Date Filed

2-8-1990

Language

en

File Format

application/pdf

Share

COinS